about
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a reviewHypoxia-inducible factors and the response to hypoxic stressPPAR-gamma: a thrifty transcription factorT2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor gamma binding propertiesStructural basis for telmisartan-mediated partial activation of PPAR gamma(+)-Rutamarin as a Dual Inducer of Both GLUT4 Translocation and Expression Efficiently Ameliorates Glucose Homeostasis in Insulin-Resistant MiceAlzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and GammaPPARalpha governs glycerol metabolismMetabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma.MBX-102/JNJ39659100, a novel peroxisome proliferator-activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edema.Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice.Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus.Thermodynamics in Gliomas: Interactions between the Canonical WNT/Beta-Catenin Pathway and PPAR GammaGene-nutrient interactions with dietary fat modulate the association between genetic variation of the ACSL1 gene and metabolic syndromePharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective.Peroxisome proliferator-activated receptor-gamma: too much of a good thing causes harmEnhanced bone formation in lipodystrophic PPARgamma(hyp/hyp) mice relocates haematopoiesis to the spleenConjugated linoleic acid in humans: regulation of adiposity and insulin sensitivityDevelopmental programming: differential effects of prenatal testosterone excess on insulin target tissuesNonhuman primates and other animal models in diabetes research.Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderlyCoronary microvascular dysfunction in diabetes mellitus: A reviewPolyunsaturated Fatty Acids Modulate the Association between PIK3CA-KCNMB3 Genetic Variants and Insulin ResistanceLiver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.A small volatile bacterial molecule triggers mitochondrial dysfunction in murine skeletal muscle.A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA"PPARgamma and metabolism: insights from the study of human genetic variants.Nutrigenetics: where next for the foods industry?Oncogenic steroid receptor coactivator-3 is a key regulator of the white adipogenic program.Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis.Effects of CP-900691, a novel peroxisome proliferator-activated receptor α, agonist on diabetic nephropathy in the BTBR ob/ob mouseThe human sirtuin family: evolutionary divergences and functions.Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS).Regulation of SREBPs by Sphingomyelin in Adipocytes via a Caveolin and Ras-ERK-MAPK-CREB Signaling PathwayIrbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinedionesSelective targeting of PPARγ by the natural product chelerythrine with a unique binding mode and improved antidiabetic potency.Peroxisome proliferator-activated receptor gamma: the more the merrier?PPARgamma in human and mouse physiologyAssociation of NCOA3 polymorphisms with Dyslipidemia in the Chinese Han population.
P2860
Q24561401-12B28E01-8959-4A92-876D-60B81C5C2F77Q24629323-7FAFCE5B-C3A5-4BF6-A4E6-D2A5B3CCECE8Q25255001-9F95324F-F507-4098-987B-681732B1FD2EQ27649827-4854BFFA-1C62-40EB-A352-47A3ECC6AA03Q27677426-C297E2E1-CCB9-4E53-BEEB-6306A3F07A77Q27677636-5927BA25-E326-4D9D-AFB3-C4FBDA96A975Q28075617-6465361F-2E16-4014-9237-2D1DF3AD230FQ28507952-3FFCDC17-EFF7-461C-B17C-4A0761BC3634Q33347137-276D57D3-B5EA-48F4-9AB7-D1B52E724A42Q33642155-D250634F-A73E-49B3-99FA-798E022684D6Q33717836-96D2CB86-94D6-46B8-ACAF-00D047EF1EFDQ33727061-06522638-5D11-4F85-BA29-11B0917DE335Q33748280-1099F38A-EE09-4125-80AF-41C8AA95E070Q33902018-E248D4D2-567A-440A-8A66-EFF9DCCFDEAFQ33993320-23714487-8324-4298-9365-4B39577C68EBQ34165847-F85271AE-32C6-4073-BFF1-9ABDFB873D48Q34166268-67388109-407E-4914-BD84-F3E707801FE3Q34195708-53FBA7AC-B33C-40E7-97C1-C359D685CCCFQ34197789-4596CE8C-1FA3-4D98-930F-E1D7A3B9C2F1Q34286456-CF85F35D-D369-41F1-8D29-D07B51C07BA9Q34386587-8FEBF2F5-4B26-4268-A8C8-944B2D5947F9Q34427072-253C64C9-E75B-45DB-B3F7-3650DEBF9F62Q34797066-6BB02786-501D-431B-83E0-A3DEF1A0164AQ34835012-D028E3A1-B93B-4EED-9E5B-7E253A29C21EQ35009877-48A2DAEF-E279-46E9-9224-81E1F6A5E143Q35072984-D278D440-8D1D-4763-9034-D7F3C121C84CQ35200033-10EDB7E7-845E-4680-AFC2-D53204D6FBB4Q35204071-B7EBD1F1-A73A-43D7-8642-28CBD58D7F0DQ35215073-1F4C4FDE-194A-4025-920F-AFBA9011DB39Q35237706-3EA899A6-A0E7-416D-BECB-BCBAAA4572D8Q35498269-D828FA07-AECC-475A-BD01-B5B6A07C6CB9Q35592289-50955EC3-0532-4574-9F90-C18238C13F9AQ35606054-BB1DDF00-5890-45AF-ACEC-A59B6508C510Q35731006-7E0A9AAC-3ECA-4FD0-B75C-82843E68CDA9Q35753591-945509C3-98B9-4332-9C88-885546CAEF55Q35794061-30BCC24B-E4FE-4190-9257-4461A8FB8C2AQ35860302-B842E044-D445-4687-AD38-8F40DD3F0A60Q36018557-D3C7BB32-E023-4757-975F-2BFA8F6723D8Q36063081-EC65EEFA-4745-46D8-A96C-25A4C37FB407Q36142671-D8836BDE-E59C-42A6-B9A0-EDC0A2A3A018
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
PPAR
@nl
PPAR(gamma) and glucose homeostasis.
@ast
PPAR(gamma) and glucose homeostasis.
@en
type
label
PPAR
@nl
PPAR(gamma) and glucose homeostasis.
@ast
PPAR(gamma) and glucose homeostasis.
@en
prefLabel
PPAR
@nl
PPAR(gamma) and glucose homeostasis.
@ast
PPAR(gamma) and glucose homeostasis.
@en
P1476
PPAR(gamma) and glucose homeostasis.
@en
P2093
Frédéric Picard
P304
P356
10.1146/ANNUREV.NUTR.22.010402.102808
P407
P50
P577
2002-01-04T00:00:00Z